U.S. Food and Drug Administration (FDA), Center for Drug Evaluation and Research (CDER), Real-World Application for Innovation and Development (RAPID) platform. 
‍

Services Include:

• Support for a Research Exploration/Experimentation Sandbox 
• Enable scientific discovery and commercial research through the exploration of emerging technologies that could be implemented in FDA’s RAPID environment. 
• Developing innovative proof of concepts to inform on the feasibility technical approaches to support FDA regulatory review. 
• Support FDA Scientists in the development of proof of concepts. 
• Document discovery and findings for all projects maintained in the 
• Exploration/Experimentation RAPID Sandbox. 
• Support for a Production Environment for Deploying Applications 
• Support the implementation and enhancement of tools and applications in the RAPID environment. 
• Designing, developing, scaling, and testing technical solutions for deployment in FDA’s IT Infrastructure. 

Food and Drug Administration (FDA) Center for Drug Evaluation and Research (CDER) Office of Computational Science (OCS) Regulatory Review Blanket Purchase Agreement (BPA).

Service include technical expertise that will support FDA’s ability to continue to modernize and transform its regulatory review approach meet the challenges associated with pursuing advances in medical products that deliver more benefits with fewer side effects 

‍